Skip to main content
. 2022 Aug 31;13:921837. doi: 10.3389/fgene.2022.921837

FIGURE 1.

FIGURE 1

Construction of a prognostic model for stage I–III LUSC patients according to three CSRGs. (A) Identifying 12 prognostic CSRGs using univariate Cox regression analysis. (B) Principal component analysis (PCA) based on the expression levels of three CSRGs in the TCGA training set. (C) Distribution of risk scores, survival status, and three CSRG expression panels in the training set. (D) Kaplan–Meier survival analysis of OS between the high-risk and low-risk groups. (E) Time-dependent ROC for 1-, 3-, and 5-year OS predictions for the CSRG prognostic signature in the training set.